Cargando…
Statin Use and Markers of Immunity in the Doetinchem Cohort Study
It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797719/ https://www.ncbi.nlm.nih.gov/pubmed/24147031 http://dx.doi.org/10.1371/journal.pone.0077587 |
_version_ | 1782287653105827840 |
---|---|
author | De Jong, Hilda J.I. Damoiseaux, Jan G.M.C. Vandebriel, Rob J. Souverein, Patrick C. Gremmer, Eric R. Wolfs, Mia Klungel, Olaf H. Van Loveren, Henk Cohen Tervaert, Jan Willem Verschuren, W.M. Monique |
author_facet | De Jong, Hilda J.I. Damoiseaux, Jan G.M.C. Vandebriel, Rob J. Souverein, Patrick C. Gremmer, Eric R. Wolfs, Mia Klungel, Olaf H. Van Loveren, Henk Cohen Tervaert, Jan Willem Verschuren, W.M. Monique |
author_sort | De Jong, Hilda J.I. |
collection | PubMed |
description | It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, immunoglobulin E (IgE) antibodies and the presence of autoantibodies (antinuclear antibodies (ANA) and IgM rheumatoid factor (RF)) in the general population. We conducted a nested case-control study within the population-based Doetinchem cohort. Data from health questionnaires, serological measurements and information on medication from linkage to pharmacy-dispensing records were available. We selected 332 statin users (cases) and 331 non-users (controls), matched by age, sex, date of serum collection, history of cardiovascular diseases, diabetes mellitus type II and stroke. Multivariate regression analyses were performed to estimate effect of statins on the immune system. The median level of CRP in statin users (1.28 mg/L, interquartile range (IQR): 0.59-2.79) was lower than in non-users (1.62 mg/L, IQR: 0.79-3.35), which after adjustment was estimated to be a 28% lower level. We observed an inverse association between duration of statin use and CRP levels. Elevated levels of IgE (>100 IU/mL) were more prevalent in statin users compared to non-users. A trend towards increased levels of IgE antibodies in statin users was observed, whereas no associations were found between statin use and levels of neopterin or the presence of autoantibodies. In this general population sub-sample, we observed an anti-inflammatory effect of statin use and a trend towards an increase of IgE levels, an surrogate marker for Th (helper) 2 responses without a decrease in neopterin levels, a surrogate marker for Th1 response and/or self-tolerance. We postulate that the observed decreased inflammatory response during statin therapy may be important but is insufficient to induce loss of self-tolerance. |
format | Online Article Text |
id | pubmed-3797719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37977192013-10-21 Statin Use and Markers of Immunity in the Doetinchem Cohort Study De Jong, Hilda J.I. Damoiseaux, Jan G.M.C. Vandebriel, Rob J. Souverein, Patrick C. Gremmer, Eric R. Wolfs, Mia Klungel, Olaf H. Van Loveren, Henk Cohen Tervaert, Jan Willem Verschuren, W.M. Monique PLoS One Research Article It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, immunoglobulin E (IgE) antibodies and the presence of autoantibodies (antinuclear antibodies (ANA) and IgM rheumatoid factor (RF)) in the general population. We conducted a nested case-control study within the population-based Doetinchem cohort. Data from health questionnaires, serological measurements and information on medication from linkage to pharmacy-dispensing records were available. We selected 332 statin users (cases) and 331 non-users (controls), matched by age, sex, date of serum collection, history of cardiovascular diseases, diabetes mellitus type II and stroke. Multivariate regression analyses were performed to estimate effect of statins on the immune system. The median level of CRP in statin users (1.28 mg/L, interquartile range (IQR): 0.59-2.79) was lower than in non-users (1.62 mg/L, IQR: 0.79-3.35), which after adjustment was estimated to be a 28% lower level. We observed an inverse association between duration of statin use and CRP levels. Elevated levels of IgE (>100 IU/mL) were more prevalent in statin users compared to non-users. A trend towards increased levels of IgE antibodies in statin users was observed, whereas no associations were found between statin use and levels of neopterin or the presence of autoantibodies. In this general population sub-sample, we observed an anti-inflammatory effect of statin use and a trend towards an increase of IgE levels, an surrogate marker for Th (helper) 2 responses without a decrease in neopterin levels, a surrogate marker for Th1 response and/or self-tolerance. We postulate that the observed decreased inflammatory response during statin therapy may be important but is insufficient to induce loss of self-tolerance. Public Library of Science 2013-10-16 /pmc/articles/PMC3797719/ /pubmed/24147031 http://dx.doi.org/10.1371/journal.pone.0077587 Text en © 2013 De Jong et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article De Jong, Hilda J.I. Damoiseaux, Jan G.M.C. Vandebriel, Rob J. Souverein, Patrick C. Gremmer, Eric R. Wolfs, Mia Klungel, Olaf H. Van Loveren, Henk Cohen Tervaert, Jan Willem Verschuren, W.M. Monique Statin Use and Markers of Immunity in the Doetinchem Cohort Study |
title | Statin Use and Markers of Immunity in the Doetinchem Cohort Study |
title_full | Statin Use and Markers of Immunity in the Doetinchem Cohort Study |
title_fullStr | Statin Use and Markers of Immunity in the Doetinchem Cohort Study |
title_full_unstemmed | Statin Use and Markers of Immunity in the Doetinchem Cohort Study |
title_short | Statin Use and Markers of Immunity in the Doetinchem Cohort Study |
title_sort | statin use and markers of immunity in the doetinchem cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797719/ https://www.ncbi.nlm.nih.gov/pubmed/24147031 http://dx.doi.org/10.1371/journal.pone.0077587 |
work_keys_str_mv | AT dejonghildaji statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT damoiseauxjangmc statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT vandebrielrobj statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT souvereinpatrickc statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT gremmerericr statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT wolfsmia statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT klungelolafh statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT vanloverenhenk statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT cohentervaertjanwillem statinuseandmarkersofimmunityinthedoetinchemcohortstudy AT verschurenwmmonique statinuseandmarkersofimmunityinthedoetinchemcohortstudy |